This systematic review and meta-analysis confirms prolonged magnesium intake substantially lowers C-reactive protein in individuals with metabolic syndrome, but does not reinforce the positive impact of magnesium intake on additional serum inflammatory indicators including IL-6, TNF-α, NO, MDA, TAC, and GSH in this population. This evidence concerns the gene CRP and metabolic syndrome.